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ABSTRACT
Objective: The aim of this study was to evaluate our
experience with laparoscopic surgery in children with
sickle cell disease.
Methods: A retrospective chart review was performed to
analyze the indication for surgery, perioperative man-
agement, surgical technique, complications, duration of
hospitalization, and outcome. One pediatric surgeon per-
formed all procedures.
Results: Thirteen children underwent laparoscopic sur-
gery for the following indications: symptomatic
cholelithiasis/cholecystitis in 9; recurrent splenic seques-
tration in 3; and hypersplenism/symptomatic cholelithia-
sis in 1. The 7 boys and 6 girls had a median age of 7.8
years. Patients undergoing splenectomy only were
younger than those undergoing cholecystectomy (medi-
an age, 3.6 years versus 11.5 years, respectively). Four
children underwent endoscopic retrograde cholan-
giopancreatography (ERCP) and sphincterotomy because
of common bile duct dilatation and stones. Twelve
patients received packed red blood cell transfusions prior
to surgery. The median operative time was 150 minutes,
and the median hospitalization was 3 days. Four patients
suffered postoperative complications (2 with acute chest
syndrome, 1 with recurrent abdominal pain, and 1 with
priapism). The patient with abdominal pain was found to
have a retained stone in the common bile duct, which
was retrieved via endoscopic retrograde cholangiopan-
creatography and sphincterotomy. All complications
resolved with medical management.
Conclusions: Laparoscopic surgery is safe in children
with sickle cell disease. Meticulous attention to perioper-
ative management, transfusion guidelines, and pul-
INTRODUCTION
Homozygous hemoglobin S (sickle cell) disease is a qual-
itative hemoglobinopathy whose clinical hallmarks are
hemolytic anemia and vaso-occlusive/sickle cell crises.1
Children so affected can suffer gallbladder disease in the
form of cholecystitis and/or cholelithiasis and splenic
sequestration. Cholelithiasis can cause severe bouts of
abdominal pain and considerable morbidity. Splenic
sequestration can rapidly progress to hypovolemic shock
and death. Clearly, prompt medical attention is mandato-
ry, especially for sequestration crises.
Cholecystectomy can cure gallbladder disease, and
splenectomy will prevent subsequent splenic sequestra-
tion crises. However, children with sickle cell disease
require meticulous perioperative care and long-term post-
operative follow-up. Postsplenectomy bacterial infections
can be quite severe with a possibly fatal outcome.
Cholecystectomy should be performed as an elective pro-
cedure in all symptomatic patients with cholelithiasis,
because emergency surgery during episodes of acute
cholecystitis is associated with unacceptable morbidity.
Splenectomy is best performed after the second seques-
tration crisis. With the advent of laparoscopic techniques,
the need for postoperative analgesics and the length of
hospitalization have been reduced.2 The laparoscopic
approach, moreover, may reduce the morbidity of surgery
in children with sickle cell disease.
In the present report, we describe our single-institution
experience with 13 children with sickle cell disease who
underwent laparoscopic surgery for cholelithiasis and/or
splenomegaly associated with recurrent splenic sequestra-
tion crises or hypersplenism.
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monary care may decrease the incidence of acute chest
syndrome.
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PATIENTS AND METHODS
We reviewed the charts of 370 children with sickle cell dis-
ease treated at Westchester Medical Center in Valhalla,
New York, from 1995 to 2000. All are currently active
patients in the pediatric hematology/oncology service.
Thirteen children in this patient population were found to
have undergone laparoscopic surgery. Nine of them
underwent laparoscopic cholecystectomy because of
symptomatic cholelithiasis; 3 underwent laparoscopic
splenectomy because of recurrent splenic sequestration;
and 1 underwent laparoscopic cholecystectomy/splenecto-
my because of symptomatic cholelithiasis and hyper-
splenism. Two of these patients have been previously
described.3 One pediatric surgeon (GS) performed all the
laparoscopic surgeries. Patients undergoing splenectomy
had preoperative abdominal ultrasound examinations to
exclude cholelithiasis and had received at least 2 pneumo-
coccal vaccinations. Four patients undergoing cholecystec-
tomy had preoperative endoscopic retrograde cholan-
giopancreatography (ERCP) and sphincterotomies, and 2
underwent intraoperative cholangiograms to assist in iden-
tifying anatomic landmarks.
Operative Technique
The laparoscopic cholecystectomy was done by careful
identification and isolation of the cystic duct and cystic
artery. Two hemoclips were applied to the cystic duct
proximal to the common bile duct, and 1 was applied dis-
tally. The junction of the cystic duct and common bile duct
was always identified to prevent inadvertent damage to the
common bile duct. Operative cholangiogram was per-
formed only for specific indications. The gallbladder was
removed from the gallbladder bed with monopolar or
bipolar electrocautery. In the single case in which chole-
cystectomy was combined with splenectomy, the chole-
cystectomy was done first, with the patient in the supine
position followed by the laparoscopic splenectomy
(detailed below). An additional 5-mm port was added in
the right upper quadrant for the cholecystectomy. 
The splenectomy was performed with the patient in the
right lateral decubitus position. This position allowed for
the spleen to be suspended in the left upper quadrant by
the splenic ligaments. At least 3 ports, as always required,
were used for this procedure: a 5-mm port in the epigas-
trium, a 12-mm port in the left lower quadrant, and a 5-
mm port in between. The 12-mm port was utilized to intro-
duce the automatic endoscopic stapler (Endo GIA 30; US
Surgical Corporation, Norwalk, CT) and subsequently to
place the plastic specimen-retrieval bag (Endo Catch; US
Surgical Corporation) to remove the spleen. A fourth port
was needed in some cases to manipulate the spleen (it
could be a mini 3-mm port or a 5-mm port), and it was
placed in the left flank posteriorly to dissect behind the
spleen. In most cases, the Harmonic scalpel was used
(Ethicon, Johnson & Johnson Corporation, Somerville, NJ),
but in a few cases, the bipolar cutting forceps (Everest
Medical Corporation, Minneapolis, MN) were used. The
use of surgical clips was kept to a minimum whenever
possible, because they can interfere with the automatic
stapler and cause bleeding.
The gastrosplenic ligament was divided at first. Initially,
only the division of ligaments that was needed to expose
the splenic hilum was performed. The remaining liga-
ments were preserved until the end of the operation to
keep the spleen suspended in the left upper quadrant. The
first branch of the blood supply from the gastroepiploic
artery to the lower pole of the spleen was then divided.
The splenic hilum was divided close to the spleen with the
Endo GIA 30-2.0 vascular staples. Generally, 2 or 3 appli-
cations were necessary to completely divide the blood
supply, including the short gastric vessels; in some cases,
the remaining short gastric vessels could be divided with
the Harmonic scalpel or the bipolar cautery. During appli-
cation of the stapler, care was exercised to avoid the tail
of the pancreas and the greater gastric curvature. After the
blood supply had been divided, all the ligaments were
transected with the bipolar forceps or Harmonic scalpel.
The spleen was placed inside the Endo Catch, and the
opening of the bag was pulled out through the 12-mm
port. The spleen was fragmented inside the bag with the
finger or a ring blunt clamp and suction. This part of the
procedure required careful attention to prevent rupture of
the bag, which was watched from the inside. The spleen
could be removed in small pieces. After the spleen was
removed, care was taken to avoid contamination of the
wounds or abdomen with splenic tissue to prevent
splenosis.
At the beginning and at the end of the operation, a care-
ful and methodical search was done to exclude accessory
spleens. Long-acting local anesthesia (bupivacaine) was
applied in all ports, and finally the ports were closed in
the usual manner.RESULTS
Thirteen children (7 boys and 6 girls) with sickle cell dis-
ease underwent laparoscopic surgery. The median age of
the entire group was 7.8 years (range, 2.5 to 16.8 years);
that of the splenectomy-only group was 3.6 years (range,
2.5 to 7.5 years), and that of the cholecystectomy group
was 11.5 years (range, 7.8 to 16.8 years). The median
operative time was 150 minutes (range, 90 to 310 min-
utes). The patient who underwent a combined cholecys-
tectomy/splenectomy had an operative time of 300 min-
utes. In addition, 1 patient undergoing cholecystectomy
required an intraoperative cholangiogram because of a dif-
ficult biliary anatomy and had an extended operative time
of 310 minutes.
Nine patients received preoperative blood transfusions
with a median of 10 cc/kg of packed red blood cells
(range, 4 to 15 cc/kg). The median hemoglobin prior to
transfusion was 8.4 g/dL (range, 6.1 to 9 g/dL), and the
median hemoglobin posttransfusion was 9.8 g/dL (range,
9.2 to 13.2 g/dL). Three patients had received packed red
blood cell transfusions 3 to 4 weeks prior to surgery: 1 for
priapism refractory to intravenous hydration and anal-
gesics, 1 for refractory pain during a vaso-occlusive crisis,
and 1 for a second splenic sequestration crisis. One patient
was not transfused. Her hemoglobin was 8.8 g/dL, and she
did not suffer any perioperative complications.
The most common postoperative analgesic used was mor-
phine sulfate. Eleven patients required a median of 24
hours of morphine sulfate (range, 24 hours to 6 days).
One patient with postoperative acute chest syndrome and
1 with persistent abdominal pain required 4 and 6 days of
intravenous morphine sulfate, respectively. One patient’s
postoperative pain was controlled with 24 hours of intra-
venous meperidine, and another patient required only
acetaminophen with codeine. A second patient with post-
operative acute chest syndrome required 5 days of aceta-
minophen and oxycodone after 24 hours of intravenous
morphine sulfate.
The median postoperative hospitalization was 3 days
(range, 2 to 12.4 days). The 4 patients who suffered post-
operative complications (2 with acute chest syndrome, 1
with priapism, and 1 with persistent abdominal pain) had
extended hospitalizations of 4, 6, 7, and 12 days. In addi-
tion to the pain management noted above, the patients
with acute chest syndrome were treated with oxygen,
intravenous hydration and antibiotics, and incentive
JSLS(2002)6:29-33 31
spirometry. Diagnostic imaging in the patient with persist-
ent abdominal pain showed a retained common bile duct
stone and perihepatic fluid. An ERCP was performed that
showed a dilated common bile duct and a stone in the dis-
tal common bile duct. The stone was extracted and a
sphincterotomy performed.
Four patients underwent laparoscopic splenectomy (1 in
combination with cholecystectomy) for recurrent splenic
sequestration (n = 3) and 1 for hypersplenism. In 3
patients, the median splenic weight was 200 grams (range,
120 to 558 grams). One patient required a small incision
in the left lower quadrant to assist in removing an 18 x 13
x 6-centimeter spleen weighing 558 grams.
The histopathology of the gallbladders showed chronic
cholecystitis and cholelithiasis in each case. The
histopathology of the spleens showed sinusoidal conges-
tion with marked sickling erythrostasis. Two spleens had
evidence of focal hemosiderosis, and in the 2 oldest
patients (aged 7.5 and 7.8 years), evidence was present of
atrophy of the splenic parenchyma.
No patient has had any long-term postoperative compli-
cations during a median follow-up time of 19 months
(range, 1 month to 71 months). Two patients have
required hospitalizations for recurrent vaso-occlusive
crises, and 1 patient has required 2 admissions for post-
splenectomy fever. In neither case did the patient with
fever appear ill, and her hospital course was uneventful.
DISCUSSION
Our single-institution experience with laparoscopic sur-
gery shows that it is a safe and effective approach to man-
aging surgical problems in children with sickle cell dis-
ease. Three patients had complications related to sickle
cell disease, and 1 patient had a retained stone in the com-
mon bile duct. Each complication was successfully man-
aged, with no resultant deaths.
Cholelithiasis is a common clinical problem encountered
in children with sickle cell disease,1 and those with
increased body mass index, reticulocyte counts, and levels
of alkaline phosphatase are more likely to form stones.4,5
Indeed, cholecystectomy is the most common surgical
procedure performed on patients with sickle cell disease.6
In pediatric patients with cholelithiasis, a careful search for
choledocholithiasis should be undertaken,7 and the pres-
ence of biliary sludge should prompt a referral to a pedi-
atric surgeon.8 However, in asymptomatic children withPerioperative Management in Children with Sickle Cell Disease Undergoing Laparoscopic Surgery, Sandoval C et al.
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cholelithiasis, observation seems prudent.5
With the advent of laparoscopic techniques, postoperative
analgesia use and the duration of hospitalization have
decreased. Eight studies in children with sickle cell disease
and symptomatic cholelithiasis have shown that the tech-
nique is safe and effective.9-16 The median hospitalization
in these studies ranged from 1.6 to 2.3 days, and, when
compared with open cholecystectomy,10,14 was shorter for
laparoscopic surgery. Most of the complications observed,
especially acute chest syndrome, were related to sickle cell
disease.
In our series, the median postoperative hospitalization was 3
days in the patients undergoing cholecystectomy. Interes-
tingly, the 4 postoperative complications occurred in patients
undergoing cholecystectomy (1 combined with splenecto-
my). The median operative time for these patients was
longer than that for the patients undergoing cholecystectomy
without postoperative complications (220 minutes versus 150
minutes, respectively). Perhaps the longer operative/anes-
thesia times of 300 and 310 minutes, in combination with a
posttransfusion hemoglobin of 13.2 g/dL in 1 child, may
have contributed to the development of the 2 cases of acute
chest syndrome. It is noteworthy that, of 6 postoperative
episodes of acute chest syndrome observed at another insti-
tution, 5 occurred after laparoscopic surgery and 1 after an
open procedure.17 Perhaps the benefits of laparoscopic sur-
gery do not translate into a decreased incidence of acute
chest syndrome; thus, meticulous perioperative and pul-
monary care is mandatory.
Splenic sequestration is a principal cause of death in chil-
dren with sickle cell disease.18,19 Deaths result from hypo-
volemic shock. Recurrences are quite common among sur-
vivors of first attacks,20 and most centers recommend
splenectomy after the first recurrence.21 Splenectomy does
not increase the risk of death or bacteremic illnesses in
children with sickle cell disease treated in this manner.21
Indeed, splenectomy is safe and beneficial in children with
sickling syndromes.22
In our series, all 3 patients undergoing splenectomy alone
had an uneventful hospital course. Each child was vacci-
nated against pneumococcal disease and has been main-
tained on penicillin prophylaxis. One child with hyper-
splenism required a small incision in the left lower quad-
rant to facilitate removal of a large spleen. In 1 study, 17
children with sickling syndromes had splenectomy with
massive splenomegaly (spleen weight of approximately
1000 grams).23 Although the morbidity was slightly higher
than that in patients with smaller spleens, the procedure
was found to be generally safe. Newer techniques that are
becoming available obviate the need for conversion to an
open procedure, use of large and cumbersome intracor-
poreal bags, and the creation of additional incisions.
In our series, 9 patients received preoperative transfusions
to attain a posttransfusion hemoglobin of 10 to 11 g/dL.
One patient’s posttransfusion hemoglobin was 13.2 g/dL,
and this high level of hemoglobin, in addition to the pro-
longed operative/anesthesia time noted above, may have
resulted in the case of acute chest syndrome that this
patient developed. Current guidelines recommend that
simple transfusion to increase the hemoglobin to 10 g/dL
results in favorable postoperative outcomes.24
CONCLUSIONS
Laparoscopic surgery is the treatment of choice for children
with sickle cell disease and symptomatic gallbladder dis-
ease, recurrent splenic sequestration, and hypersplenism.
Sickle cell disease-related postoperative complications are
the principal causes of morbidity. Meticulous attention to
perioperative management, transfusion guidelines, and
pulmonary status may further decrease the incidence of
acute chest syndrome after laparoscopy.
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